Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jul 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1829151000001117 | Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1829161000001119 | Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | Has VMP | Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials | true | Inferred relationship | Existential restriction modifier | ||
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | Has dispensed dose form | Powder and suspension for suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | Has specific active ingredient | Varicella-Zoster surface antigens | true | Inferred relationship | Existential restriction modifier | ||
| Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Shingrix (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials (GlaxoSmithKline UK Ltd) 1 vial | Is a | True | Shingles (Herpes Zoster) adjuvanted recombinant vaccine powder and suspension for suspension for injection 0.5ml vials 1 vial | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR